8 completed, 2 active not recruiting, 2 recruiting, 1 enrolling by invitation. 7 Phase 3, 4 Phase 4, 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Active not recruiting 2, Recruiting 1 |
| Phase 4 | 4 | Completed 4 |
| Not applicable | 2 | Enrolling by invitation 1, Recruiting 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow JHSPH Center for Clinical Trials: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Social Needs App for Oncology Patients Phase II Carealth Phone App, Let's Talk: Sharing information about Family Cancer Risk - Cancer, Social Support (Formal and Informal) | Not applicable | Enrolling by invitation | JHSPH Center for Clinical Trials | 722 | 2024-10-01 | 2024-11-14 |
| Early Intervention to Promote Cardiovascular Health of Mothers and Children ENRICH, Usual Home Visiting - Cardiovascular Health | Not applicable | Recruiting | JHSPH Center for Clinical Trials | 6618 | 2024-06-19 | 2026-04-13 |
| Multi-Center Clean Air Randomized Controlled Trial in COPD Air cleaner, Sham air cleaner - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Recruiting | JHSPH Center for Clinical Trials | 770 | 2024-05-24 | 2026-07-31 |
| Dronabinol for Agitation in Dementia Crossover Trial Dronabinol - Dementia Moderate, Dementia Severe | Phase 2 | Withdrawn | Ralph H. Johnson VA Medical Center | 2023-11-01 | 2024-07-05 | |
| Natural Versus Programmed Frozen Embryo Transfer (NatPro) Modified natural cycle, Programmed cycle - Pregnancy Related, Pre-Eclampsia | Phase 3 | Active not recruiting | JHSPH Center for Clinical Trials | 788 | 2020-09-16 | 2025-05-16 |
| Adalimumab vs. Conventional Immunosuppression for Uveitis Trial Adalimumab (ADA), Conventional immunosuppression (CON) - Uveitis | Phase 3 | Completed | JHSPH Center for Clinical Trials | 227 | 2019-09-16 | 2025-05-16 |
| Escitalopram for Agitation in Alzheimer's Disease Escitalopram, Placebo - Dementia | Phase 3 | Active not recruiting | JHSPH Center for Clinical Trials | 187 | 2018-01-03 | 2025-01-31 |
| Losartan Effects on Emphysema Progression Losartan, Placebo - Emphysema | Phase 4 | Completed | JHSPH Center for Clinical Trials | 220 | 2017-05-23 | 2022-06-01 |
| Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg, Intravitreal Ranibizumab 0.5 mg - Uveitis, Macular Edema | Phase 3 | Completed | JHSPH Center for Clinical Trials | 194 | 2017-03-09 | 2023-07-10 |
| PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial Periocular triamcinolone 40 mg, Intravitreal triamcinolone 4 mg, Dexamethasone intravitreal implant - Macular Edema, Uveitis | Phase 3 | Completed | JHSPH Center for Clinical Trials | 192 | 2015-06-16 | 2018-12-04 |
| Study of Asthma and Nasal Steroids Mometasone Furoate monohydrate, Placebo - Asthma, Rhinitis | Phase 4 | Completed | JHSPH Center for Clinical Trials | 388 | 2010-09-01 | 2015-11-30 |
| Citalopram for Agitation in Alzheimer's Disease citalopram, placebo - Alzheimer's Disease, Agitation | Phase 3 | Completed | JHSPH Center for Clinical Trials | 186 | 2009-07-01 | 2014-06-27 |
| Multicenter Uveitis Steroid Treatment (MUST) Trial fluocinolone acetonide intraocular implant, oral corticosteroid with immunosuppressive agents as needed - Uveitis | Phase 4 | Completed | JHSPH Center for Clinical Trials | 255 | 2005-09-01 | 2016-11-25 |
| The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial fluticasone, montelukast, Fluticasone plus salmeterol - Asthma | Phase 4 | Completed | JHSPH Center for Clinical Trials | 500 | 2003-06-01 | 2015-12-09 |
Uveitis (4) · Psychomotor Agitation (3) · Alzheimer Disease (2) · Asthma (2) · Dementia (2) · Macular Edema (2) · Pulmonary Disease, Chronic Obstructive (2) · Aggression (1) · Behavior (1) · Behavioral Symptoms (1) · Bronchiolitis Obliterans Syndrome (1) · Emphysema (1) · Infertility (1) · Neoplasms (1) · Pre-Eclampsia (1)
Azathioprine (2) · Calcium Dobesilate (2) · Cyclosporine (2) · Dexamethasone (2) · Methotrexate (2) · Mycophenolic Acid (2) · Tacrolimus (2) · Adalimumab (1) · Adrenal Cortex Hormones (1) · Alkylating Agents (1) · Biological Products (1) · Chlorambucil (1) · Citalopram (1) · Cyclophosphamide (1) · Daclizumab (1)
United States (14) · Australia (4) · Canada (4) · United Kingdom (4) · India (1)
Constantine Lyketsos, MD, MHS (2) · Douglas A Jabs, MD, MBA (2) · Anne Dixon, MD (1) · Anton Porsteinsson, MD (1) · Bruce Pollock, MD (1) · Daniel Weintraub, MD (1) · Davengere Devanand, MD (1) · David Shade, Esq (1) · Douglas A Jabs, MD MBA (1) · Douglas Jabs, MD, MBA (1) · Jacobo E Mintzer, MD (1) · Jacobo Mintzer, MD (1) · James Segars, MD (1) · Janet Holbrook, PhD (1) · Janet T Holbrook, PhD, MPH (1)
PMID 17507702, PMID 20851928, PMID 21652026, PMID 21799027, PMID 21840602, PMID 21861971, PMID 22247489, PMID 22409563, PMID 23163490, PMID 24549548, PMID 24914549, PMID 25115882, PMID 26501236, PMID 26798977, PMID 28477440, PMID 30269924, PMID 31587995, PMID 32918964, PMID 35649189, PMID 37172782, PMID 37318415, PMID 37461659, PMID 38925285, PMID 39497092, PMID 40133524
U10EY024527 (2), R01AG031348 (1), R01AG052510 (1), U10EY014660 (1), U24HL163114 (1), U24HL169566 (1)